Loading...
XNAS
VERO
Market cap3mUSD
Dec 04, Last price  
1.94USD
1D
7.18%
1Q
-14.91%
IPO
-99.91%
Name

Restoration Robotics Inc

Chart & Performance

D1W1MN
XNAS:VERO chart
P/E
P/S
0.06
EPS
Div Yield, %
Shrs. gr., 5y
4.54%
Rev. gr., 5y
-10.10%
Revenues
65m
-15.09%
17,230,00015,600,00021,297,00021,956,000110,406,00078,014,000105,622,00099,497,00076,354,00064,833,000
Net income
-47m
L+26.16%
-22,971,000-21,846,000-17,842,000-28,726,000-42,295,000-82,818,000-22,141,000-43,584,000-37,250,000-46,996,000
CFO
-11m
L-13.94%
-24,118,000-16,164,000-19,256,000-28,699,000-39,595,000-28,650,000-19,771,000-26,980,000-12,859,000-11,066,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
IPO date
Oct 12, 2017
Employees
384
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT